1. Home
  2. GRWG vs ANIX Comparison

GRWG vs ANIX Comparison

Compare GRWG & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrowGeneration Corp.

GRWG

GrowGeneration Corp.

HOLD

Current Price

$1.78

Market Cap

96.7M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.80

Market Cap

100.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRWG
ANIX
Founded
2008
1982
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.7M
100.6M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
GRWG
ANIX
Price
$1.78
$2.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$2.50
$8.67
AVG Volume (30 Days)
694.7K
103.8K
Earning Date
05-08-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
51.22
12.82
EPS
N/A
N/A
Revenue
$193,365,479.00
$210,000.00
Revenue This Year
$5.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
142.51
N/A
52 Week Low
$0.93
$2.44
52 Week High
$2.40
$5.46

Technical Indicators

Market Signals
Indicator
GRWG
ANIX
Relative Strength Index (RSI) 71.27 43.67
Support Level $1.44 $2.44
Resistance Level $1.82 $3.12
Average True Range (ATR) 0.11 0.13
MACD 0.03 -0.03
Stochastic Oscillator 85.09 32.65

Price Performance

Historical Comparison
GRWG
ANIX

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: